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Background: Ambulatory blood pressure may be higher
or lower than clinic blood pressure. Attention has focused
on “white coat hypertension” (normal ambulatory blood
pressure elevated in the clinic). The converse phenomenon
of high ambulatory blood pressure but normal office blood
pressure—“white coat normotension”—has not been
studied.
Objective: To assess whether white coat normotension
(awake ambulatory blood pressure . 134/90 mm Hg and
clinic blood pressure , 140/90 mm Hg) is associated with
target organ damage.
Design: Cross-sectional observational study.
Setting: University hospital hypertension center and par-
ticipant work sites.
Patients: 295 clinically normotensive adults and 64 pa-
tients with sustained hypertension (elevated clinic and
ambulatory blood pressure).
Measurements: Target organ abnormalities were mea-
sured by echocardiography and arterial ultrasonography
in 61 patients with white coat normotension, 234 with
sustained normotension (normal clinic and ambulatory
blood pressure), and 64 with sustained hypertension.
Results: Patients with white coat normotension were
older; had higher body mass indices, serum creatinine
concentrations, and glucose levels; and a higher preva-
lence of current smokers. Left ventricular mass index and
relative wall thickness were higher by 13 g/m2 (CI, 8 to18
g/m2) and by 0.03 (CI, 0.01 to 0.04), respectively, in patients
with white coat normotension compared with those who
had sustained normotension. Patients with white coat nor-
motension and those with sustained hypertension did not
differ significantly for left ventricular mass index (4 g/m2
[CI, 23 to 10 g/m2) or relative wall thickness (0.01 [CI, 20.01
to 0.03]). The prevalence of discrete atherosclerotic
plaques was similar in patients with white coat normoten-
sion (17 of 61, or 28% [CI, 17% to 39%]) and those with
sustained hypertension (17 of 64, or 27% [CI, 16% to
38%]), but the difference lost significance after adjust-
ment for age.
Conclusions: White coat normotension is associated
with left ventricular mass and carotid wall thickness similar
to those in sustained hypertension. The association of
white coat normotension with prognostically important
target organ damage may partly explain the ability of high
normal left ventricular mass and high normal clinic blood
pressure to predict subsequent hypertension and cardio-
vascular events in patients with clinical normotension.
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Epidemiologic studies have established that hy-pertension, detected by clinical blood pressure
measurement, is a major contributor to cardiovas-
cular mortality and morbidity (1, 2). Although this
relation is highly significant in large populations,
only a weak relation exists between blood pressure
and likelihood of cardiovascular complications (3).
In addition, the factors predisposing normotensive
patients to cardiovascular complications have only
been partially elucidated. One possible explanation
is that office blood pressure readings, on which the
existing epidemiologic data are based, may not con-
sistently reflect the overall blood pressure load im-
posed on the heart and arterial tree because of the
wide variations in blood pressure that occur during
normal activity.
It is now generally accepted that 24-hour ambu-
latory blood pressure is more closely associated with
target organ damage and future cardiovascular
events than isolated blood pressure readings taken
in the clinic (4–6). However, a close correlation
between clinic blood pressure and left ventricular
mass has been reported when multiple readings in
well-standardized conditions are done (7, 8). Ambu-
latory blood pressure may be higher or lower than
clinic blood pressure, and attention has been fo-
cused on “white coat hypertension” (elevated clinic
blood pressure with normal ambulatory blood pres-
sure) (9–11). However, the converse, logically im-
plicit phenomenon of elevated ambulatory blood
pressure but normal clinic blood pressure—which
may be termed “white coat normotension” (12)—
has been reported in a small series (13) but has not
been studied in a large population sample.
We sought to 1) determine the prevalence of
white coat normotension in large community and
clinic samples and 2) to evaluate cardiac and vascu-
lar structure in patients classified as having sustained
normotension or sustained hypertension according to
both clinic and ambulatory blood pressure measure-
ments and in patients classified as having white coat
normotension.
Methods
Patients
The study sample was recruited from the Hyper-
tension Center of the New York Hospital–Cornell
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Medical Center and from ongoing longitudinal work
site–based studies (14, 15). Normotensive persons
(age range, 30 to 66 years) were recruited by sam-
pling at defined work sites (n 5 295); 35 of the
patients with sustained hypertension were drawn
from the clinical population attending the Hyper-
tension Center and 29 were drawn from the same
work sites as normotensive participants. Participants
recruited from work sites were enrolled, as de-
scribed elsewhere (14), by blood pressure screening
and subsequent stratification into sex and age
groups in which 60% of patients had diastolic blood
pressure less than 85 mm Hg and 40% of patients
had diastolic pressure of 85 mm Hg or greater. We
excluded persons with blood pressure greater than
160/95 mm Hg, those with clinically overt cardiovas-
cular disease, and those who were unwilling to tem-
porarily stop drug therapy. At the Hypertension
Center, we recruited consecutive patients with mild
hypertension (according to Joint National Commit-
tee [JNC] criteria) who were willing to unergo am-
bulatory blood pressure monitoring and ultrasonog-
raphy when the laboratories could accommodate
them. Normotensive patients had no history of
treatment with antihypertensive medications; hyper-
tensive patients either were previously untreated or
had not been receiving antihypertensive and other
cardioactive drugs for at least 3 weeks and as long
as 6 years before study entry. Although the clinic
was a smoke-free environment, current smokers
were not specifically instructed not to smoke before
the examination. All patients were free of clinical
evidence of coronary artery or cerebrovascular dis-
ease. The presence of valvular disease was excluded
by Doppler echocardiography.
A total of 234 patients had sustained normoten-
sion on the basis of normal clinic blood pressure
(,140/90 mm Hg) and awake ambulatory blood
pressure (,134/90 mm Hg). The latter partition
values were chosen because they represented the
90th percentiles of mean daytime systolic and dia-
stolic blood pressure recordings in normal volun-
teers (16) and were subsequently shown to be useful
in identifying patients with white coat hypertension
who had little or no target organ damage (10, 11).
Sixty-four patients had sustained hypertension (clin-
ic blood pressure $ 140 mm Hg systolic or $ 90
mm Hg diastolic; awake ambulatory blood pres-
sure $ 134 mm Hg systolic or $ 90 mm Hg diastol-
ic). White coat normotension was identified in 61
patients who had average clinic blood pressure less
than 140/90 mm Hg diastolic and awake ambulatory
blood pressure of 134 mm Hg or more systolic or
90 mm Hg or more diastolic. Patients with second-
ary forms of hypertension were excluded. All pa-
tients underwent standard blood laboratory analy-
ses, which included a lipid profile and determination
of plasma renin activity. Informed consent was ob-
tained under protocols approved by the Committee
on Human Rights in Research of Cornell University
Medical College.
Blood Pressure
Clinic blood pressure readings were taken by a
physician or a nurse on three or more occasions by
using an appropriate-sized arm cuff and a mercury
sphygmomanometer; values were recorded by using
the first and fifth phases of the Korotkoff sounds
and were rounded to the nearest 2 mm Hg. As
recommended by the fifth report of the Joint Na-
tional Committee on Detection, Evaluation, and
Treatment of High Blood Pressure (JNC-V) (17),
clinic blood pressure was determined by taking mul-
tiple measurements during at least two different
visits, separated by at least 2 weeks, that did not
include the first visit; these values were averaged to
determine the clinic blood pressure. The schedule
was set up so that the patients usually waited 10 to
15 minutes before their blood pressure was mea-
sured in the supine position.
In the same study period, ambulatory blood pres-
sure was recorded by having each patient wear a
noninvasive ambulatory blood pressure recorder
(Space Labs 90207 monitor [Space Labs, Redmond,
Washington] with an appropriate-sized cuff) for 24
hours. The monitor was placed on the nondominant
arm and was set to take blood pressure readings
every 15 minutes during the day and every 30 min-
utes at night. After each reading, patients recorded
their activity and location to allow calculation of
24-hour ambulatory blood pressure while awake,
during sleep, at work, and at home. Methods used
to validate these readings have been reported else-
where from this laboratory (16).
Echocardiography
All patients underwent M-mode and two-dimen-
sional echocardiography. The echocardiographs were
equipped with 2.5-MHz and 3.5-MHz imaging trans-
ducers. The research technician who performed the
echocardiography was aware of patients’ enrollment
source (work site or Hypertensive Center) but not
their blood pressure status. Most of the studies were
done by using an Acuson 128 echocardiograph
(Mountain View, California). Researchers who were
blinded to patients’ clinical characteristics took left
ventricular measurements from two-dimensionally
guided M-mode tracings according to recommenda-
tions of the American Society of Echocardiography
(18) or from linear measurements derived from the
two-dimensional study if the M-mode tracings were
technically inadequate (19). Measurements were
performed on up to six echocardiographic cycles by
using a digitizing tablet and were averaged. Left
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ventricular mass was calculated by using the Penn
convention and was adjusted for body surface area
(20). Left ventricular hypertrophy was considered
present if the left ventricular mass index (left ven-
tricular mass/height2.7) exceeded 49.7 g/m2.7 in men
or 47.2 g/m2.7 in women (21–23). Relative wall
thickness, a measure of left ventricular geometry,
was calculated as (2 3 posterior wall thickness)/end-
diastolic dimension. Fractional shortening, ejection
fraction, stroke volume, cardiac output, and total pe-
ripheral resistance were calculated by using standard
formulas.
Carotid Ultrasonography
All patients underwent imaging of both carotid
arteries with a Biosound Genesis II system (Esaote
Biomedica, Florence, Italy) or an Acuson ultra-
sonography system equipped with 7.0-MHz to 7.5-
MHz imaging transducers, as described elsewhere
(15). The patient lay in the supine position with
mild hyperextension of the neck to allow optimal
visualization of the common carotid artery, carotid
bulb, and extracranial internal and external carotid
arteries on both sides. Multiple projections were
used to identify any irregularity in the vessel walls.
Table 1. Characteristics of Study Patients*
Characteristic Patients with
Sustained
Normotension
(n 5 234)
Difference in Mean
Value between
Sustained Normotension
Group and White Coat
Normotension Group
(95% CI)
P
Value
Patients with White
Coat Normotension
(n 5 61)
Difference in Mean Value
between White Coat
Normotension Group
and Sustained
Hypertension Group
(95% CI)
P
Value
Age, y 44 6 9 6 (2 to 9) 0.005 50 6 8 6 (2 to 10) ,0.001
Men/women, n/n 126/108 ,0.05 11/50 NS
Ethnicity, n
Black 48 13
White 148 41
Hispanic 16 5
Other 21 2
Height, in 66.5 6 3.4 1.5 (0.3 to 2.8) 0.02 68.0 6 4.0 1.6 (0.03 to 3.10) NS
Weight, lb 159 6 28 21 (10 to 32) ,0.001 180 6 36 17 (3 to 30) NS
Body surface area, m2 1.82 6 0.19 0.13 (0.06 to 0.20) ,0.001 1.95 6 0.23 0.11 (0.02 to 0.19) NS
Body mass index, g/m2 25.2 6 3.4 1.9 (0.7 to 3.2) 0.008 27.1 6 3.8 1.2 (20.3 to 2.8) NS
Creatinine concentration, mg/dL† 0.92 6 0.16 0.07 (0.009 to 0.13) 0.025 0.99 6 0.18 0.02 (20.07 to 0.10) NS
Cholesterol level, mg/dL‡ 206 6 40 22 (8 to 37) 0.001 228 6 44 2 (217 to 20) NS
HDL cholesterol level, mg/dL‡ 53.4 6 13.5 1.7 (23.0 to 6.5) NS 51.7 6 13.7 1.4 (27.5 to 4.7) NS
Glucose level, mg/dL§ 79 6 9 10 (1 to 19) 0.04 89 6 26 8 (23 to 19) NS
Former smokers, n/n (%) 67/229 (29) NS 26/61 (43) NS
Current smokers, n/n (%) 36/229 (16) NS 14/61 (23) NS
* Unless otherwise noted, data are presented as the mean 6 SD. HDL 5 high-density lipoprotein; NS 5 not significant.
† To convert to mmol/L, multiply by 88.402.
‡ To convert to mmol/L, multiply by 0.0259.
§ To convert to mmol/L, multiply by 0.0555.
Table 2. Blood Pressure Measurements and Heart Rates in Study Patients*
Measurement Patients with Sustained
Normotension
(n 5 234)
Difference in Mean Value
between Sustained
Normotension Group
and White Coat
Normotension Group
(95% CI)
P
Value
Patients with White
Coat Normotension
(n 5 61)
Difference in Mean Value
between White Coat
Normotension Group
and Sustained
Hypertension Group
(95% CI)
P
Value
Clinic blood pressure, mm Hg
Systolic 109 6 10 13 (8 to 17) ,0.001 122 6 10 ND
Diastolic 75 6 7 5 (3 to 8) 0.016 80 6 6 ND
Awake blood pressure, mm Hg
Systolic 120 6 7 ND 139 6 6 14 (11 to 18) ,0.001
Diastolic 78 6 6 ND 89 6 6 6 (3 to 8) ,0.001
Home blood pressure, mm Hg
Systolic 119 6 8 18 (14 to 21) ,0.001 137 6 8 14 (10 to 19) ,0.001
Diastolic 76 6 6 9 (7 to 12) ,0.001 85 6 5 8 (3 to 9) ,0.001
Sleep blood pressure, mm Hg
Systolic 105 6 9 11 (8 to 16) ,0.001 116 6 9 21 (16 to 25) ,0.001
Diastolic 76 6 7 7 (4 to 10) ,0.001 69 6 8 11 (7 to 14) ,0.001
Work blood pressure, mm Hg
Systolic 121 6 8 17 (15 to 21) ,0.001 138 6 6 13 (8 to 16) ,0.001
Diastolic 79 6 6 10 (9 to 13) ,0.001 89 6 6 8 (4 to 8) ,0.001
Heart rate, beats/min 69 6 11 2 (22 to 6) NS 71 6 12 2 (23 to 7) NS
* Values are presented as the mean 6 SD. ND 5 not determined; NS 5 not significant.
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Discrete carotid atherosclerosis was defined as the
presence of localized plaque, at least 50% greater in
thickness than the surrounding wall, on any segment
of the arteries (24). A two-dimensionally guided
M-mode tracing of the distal common carotid ar-
tery, about 1 cm proximal to the carotid bulb, was
obtained and was recorded on half-inch super VHS
videotape with a simultaneous electrocardiogram.
The videotape was subsequently reviewed by re-
searchers who were blinded to patient characteris-
tics, and suitable frames for measurements were
obtained by using a frame-grabber (Imaging Tech-
nology, Inc., Woburn, Massachusetts), interfaced
with a high-resolution (640 3 480 pixel) video mon-
itor, and stored on diskettes. A reader who was
blinded to patient characteristics and blood pres-
sures took carotid measurements from the stored
images by using a mouse-driven computer program
(ARTSS, Cornell University Research Foundation,
New York, New York) after calibration for depth
and time. Measurements were obtained from sev-
eral cycles and were averaged. The intimal–medial
thickness of the far wall of the distal common ca-
rotid artery was measured at end-diastole. Standard
wall thickness measurements were never obtained at
the level of a discrete plaque. End-diastolic and
peak systolic internal dimensions of the artery were
determined by continuous tracing of the intimal–
lumen interface of the near and far walls of the
distal common carotid artery. Relative wall thick-
ness of the artery was calculated according to the
formula (2 3 end-diastolic wall thickness/end-dia-
stolic dimension). Ultrasonographic characterization
of carotid wall layers and measurement of wall
thickness have been validated by using gross and
histopathologic reference standards (25).
Statistical Analysis
Data were stored and analyzed by using the SPSS
statistical package (SPSS, Inc., Chicago, Illinois).
Continuous, normally distributed variables, ex-
pressed as the mean (6 SD), were compared among
the three patient groups by using analysis of vari-
ance followed by post hoc testing with the Scheffe
test. Comparisons were also made by using Kruskal–
Wallis nonparametric analyses, which confirmed the
significance of all reported findings. Analyses of co-
variance and a logistic regression model were used
to adjust for intergroup differences in age, sex, eth-
nicity, body mass index, diabetes mellitus, serum
cholesterol and creatinine levels, and current or pre-
vious smoking status; these variables are potential
predictors of left ventricular hypertrophy or carotid
atherosclerosis. Information on patients’ daily etha-
nol intake was not available. Chi-square statistics with
Bonferroni correction for multiple comparisons were
used to compare categorical variables between
groups. Supplemental analyses in which an indicator
variable for the origin of sustained hypertensive pa-
tients (work site or Hypertension Center) confirmed
the reported results (data not shown). A two-tailed
P value less than 0.05 was considered statistically
significant.
Role of the Funding Source
The National Heart, Lung, and Blood Institute
had no role in the collection, analysis, or interpre-
tation of data or in the decision to submit the paper
for publication.
Table 1—Continued
Patients with Sustained
Hypertension (n 5 64)
Difference in Mean Value
between Sustained
Normotension Group
and Sustained
Hypertension Group
(95% CI)
P
Value
56 6 11 12 (9 to 15) ,0.001
27/37 NS
9
52
3
0
66.4 6 3.8 0.1 (21.2 to 1.3) NS
163 6 32 4 (26 to 15) NS
1.84 6 0.22 0.02 (25.83 to 15.30) NS
25.9 6 3.7 0.7 (20.5 to 1.9) NS
0.97 6 0.20 0.05 (20.01 to 0.12) NS
230 6 40 24 (10 to 39) 0.001
53.1 6 14.0 0.3 (24.5 to 5.2) NS
97 6 53 18 (9 to 27) ,0.005
18/64 (28) NS
9/64 (14) NS
Table 2—Continued
Patients with Sustained
Hypertension (n 5 64)
Difference in Mean Value
between Sustained
Normotension Group
and Sustained
Hypertension Group
(95% CI)
P
Value
157 6 21 ND
96 6 9 ND
153 6 13 ND
95 6 10 ND
151 6 15 32 (28 to 35) ,0.001
93 6 10 17 (13 to 19) ,0.001
137 6 16 32 (29 to 36) ,0.001
81 6 11 18 (15 to 20) ,0.001
151 6 12 30 (26 to 34) ,0.001
97 6 9 18 (16 to 21) ,0.001
69 6 12 0 (24 to 4) NS
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Results
Study Sample
Characteristics of the study patients are pre-
sented in Table 1. Of the 295 clinically normoten-
sive patients, the 61 (21%) who met our criteria for
white coat normotension were older; were more
likely to be male; and had higher body mass indices,
serum creatinine concentrations, plasma glucose lev-
els, and total cholesterol levels than patients with
sustained normotension. These groups did not differ
in distribution of ethnic groups. No statistically sig-
nificant difference in high-density lipoprotein cho-
lesterol level was seen among the three groups.
Patients with white coat normotension were more
likely than those with sustained normotension to be
current or former smokers, but this difference was
not statistically significant.
In contrast, patients with white coat normoten-
sion resembled the patients with sustained hyperten-
sion in terms of body mass index, creatinine con-
centrations, and glucose levels. The white coat
normotension group contained more men and had a
lower mean age than the sustained hypertension
group. Patients with sustained hypertension were
older than those in the other two groups; they were
also less likely to be black than were patients in the
sustained normotension group. Sex distribution did
not differ between the sustained hypertension group
and the sustained normotension group.
Clinic and Ambulatory Blood Pressure
By definition, clinic systolic and diastolic blood
pressures were higher in the sustained hypertension
group than in the two normotension groups (Table
2). Clinic systolic and diastolic blood pressures were
significantly higher in the white coat normotension
group than in the sustained normotension group.
These comparisons remained statistically significant
after adjustment for age, ethnicity, and sex. Accord-
ing to JNC-V classification of clinic blood pressure
(16), white coat normotension was present in 21 of
44 (48% [95% CI, 35% to 61%]) patients with high
normal clinic blood pressure (.130/85 mm Hg but
,140/90 mm Hg), 17 of 173 (10% [CI, 6% to 16%])
patients with optimal blood pressure (,120/80 mm
Hg), and 23 of 78 (29% [CI, 19% to 30%]) patients
with intermediate blood pressure (systolic blood
pressure , 130 mm Hg or $ 120 mm Hg or dia-
stolic blood pressure , 85 mm Hg or $ 80 mm Hg).
As was expected from the defining characteristics of
patient groups, mean awake ambulatory blood pres-
sure in patients with white coat normotension fell
Table 3. Left Ventricular Structure and Function in Study Patients*
Measurement Patients with
Sustained
Normotension
(n 5 234)
Difference in Mean Values
between Sustained
Normotension Group and
White Coat Normotension
Group (95% CI)
P
Value
Patients with
White Coat
Normotension
(n 5 61)
Difference in Mean Values
between White Coat
Normotension Group and
Sustained Hypertension
Group (95% CI)
P
Value
Interventricular septal thickness, cm 0.87 6 0.11 0.09 (0.05 to 0.13) ,0.001 0.96 6 0.11 0.01 (20.04 to 0.06) NS
Left ventricular internal dimension, cm 4.80 6 0.44 0.20 (0.08 to 0.39) 0.008 5.00 6 0.44 0.06 (20.11 to 0.28) NS
Posterior wall thickness, cm 0.79 6 0.11 0.11 (0.07 to 0.15) ,0.001 0.90 6 0.11 0.02 (20.04 to 0.06) NS
Left ventricular mass, g 134 6 33 35 (22 to 48) ,0.001 169 6 40 3 (214 to 18) NS
Left ventricular index, g/m2 73 6 14 13 (8 to 18) ,0.001 86 6 16 4 (23 to 10) NS
Left ventricular mass/height2.7 32 6 6 6 (4 to 9) ,0.001 38 6 8 2 (21 to 5) NS
Prevalence of LVH, n (%) 1 (0.4) 6.6† 0.001 4 (7) 9† NS
Relative wall thickness 0.33 6 0.05 0.03 (0.001 to 0.04) ,0.001 0.36 6 0.04 0.01 (20.01 to 0.03) NS
Fractional shortening, % 36 6 4 0.002 (20.01 to 0.02) NS 37 6 5 0.02 (20.003 to 0.04) 0.03
Stroke volume, mL 71 6 17 9 (3 to 15) 0.02 80 6 19 2 (26 to 9) NS
Stroke index, mL/m2 39 6 8 2 (21 to 5) NS 41 6 8 2 (22 to 5) NS
* Unless otherwise specified, values are presented as the mean 6 SD. LVH 5 left ventricular hypertrophy; NS 5 not significant.
† Expressed as percentage points.
Table 4. Carotid Arterial Structure and Function in Study Patients*
Measurement Patients with Sustained
Normotension
(n 5 234)
Difference in Mean Values
between Sustained
Normotension Group and
White Coat Normotension
Group (95% CI)
P
Value
Patients with White
Coat Normotension
(n 5 61)
Difference in Mean Values
between White Coat
Normotension Group and
Sustained Hypertension
Group (95% CI)
P
Value
Wall thickness, mm 0.69 6 0.16 0.10 (0.05 to 0.16) ,0.001 0.79 6 0.18 0.06 (20.01 to 0.13) NS
Lumen diameter, mm 5.30 6 0.59 0.25 (0.05 to 0.50) 0.023 5.55 6 0.74 0.21 (20.09 to 0.48) NS
Cross-sectional area, mm2 13.1 6 4.2 3.0 (1.4 to 4.6) ,0.001 16.1 6 5.3 1.7 (20.3 to 3.7) NS
Relative wall thickness 0.26 6 0.06 0.03 (0.01 to 0.05) 0.004 0.29 6 0.06 0.01 (20.02 to 0.03) NS
Plaque, n (%) 35 (15) 14† ,0.05 17 (28) 0.0† NS
* Unless otherwise indicated, values are presented as the mean 6 SD. NS 5 not significant.
† Expressed as percentage points.
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between that in patients with sustained normoten-
sion and that in patients with sustained hyperten-
sion. Of note, sleep blood pressures recorded by
using an automatic recorder were also higher in
patients with white coat normotension than in those
with sustained normotension.
Left Ventricular Structure and Function
Left ventricular wall thickness, internal dimension,
and relative wall thickness were greater in patients
with white coat normotension than in those with
sustained normotension (Table 3). As a result, ab-
solute left ventricular mass, left ventricular mass
index, and left ventricular mass/height2.7 were higher
in patients with white coat normotension than in
those with sustained normotension. In contrast, pri-
mary ventricular dimensions, left ventricular mass,
and relative wall thickness in patients with white
coat normotension were statistically indistinguish-
able from those in patients with sustained hyperten-
sion. Intergroup differences in left ventricular wall
thickness and left ventricular mass remained highly
significant (P , 0.02 to P , 0.001) after adjustment
for covariates, whereas those for left ventricular
chamber size became statistically undetectable. In
parallel with these findings, left ventricular hyper-
trophy was present in 16% (10 of 64) of patients
with sustained hypertension, 7% (4 of 61) of pa-
tients with white coat normotension, and 0.4% (1 of
234) of patients with sustained normotension
(P 5 0.001). Fractional shortening was higher in pa-
tients with sustained hypertension than in those with
sustained or white coat normotension. Stroke vol-
ume was higher in patients with white coat normo-
tension than in those with sustained normotension,
but this difference was eliminated by indexation for
body size.
Carotid Artery Structure and Function
The intimal–medial thickness of the common caro-
tid artery was greater in patients with white coat
normotension than in those with sustained normo-
tension (difference of mean values, 0.10 [CI, 0.05 to
0.16]) but did not differ significantly from that in
patients with sustained hypertension (difference of
mean values, 0.06 [CI, 20.01 to 0.13]). Carotid lu-
men diameter and arterial relative wall thickness
were also greater in patients with white coat nor-
motension than in those with sustained normoten-
sion; as a result, the cross-sectional area of the
carotid wall was greater in the former group. In
multivariate analysis, the adjusted mean carotid wall
thickness in patients with white coat normotension
(0.73 6 0.01) did not differ significantly from that in
patients with sustained normotension (0.73 6 0.02)
(difference of mean values, 0.02 [CI, 20.04 to
0.07]). The adjusted mean carotid wall thickness was
0.80 6 0.02 in patients with sustained hypertension.
The mean carotid lumen diameter in patients with
sustained normotension and those with white coat
normotension (5.43 6 0.57) did not differ signifi-
cantly after adjustment for covariates. Discrete ath-
erosclerotic plaques were detected in approximately
twice as many patients with white coat hypertension
and patients with sustained hypertension than pa-
tients with sustained normotension (Table 4); this
finding was not statistically significant in multivari-
ate analysis (P . 0.2).
Discussion
Our study provides new data on cardiac and vas-
cular target organ damage in adults with normal
clinic blood pressure and various categories of am-
bulatory pressure. In our population, nearly 20% of
patients with clinic normotension had awake ambu-
latory systolic or diastolic blood pressure that ex-
ceeded previously published partition values (10). The
prevalence of white coat normotension in our study
was similar to that in a recent smaller study (13).
Our results extend and refine previous evidence
suggesting that average ambulatory measurement of
awake or 24-hour blood pressure has an important
Table 3—Continued
Patients with Sustained
Hypertension (n 5 64)
Difference in Mean Value
between Sustained
Normotension Group and
Sustained Hypertension
Group (95% CI)
P
Value
0.97 6 0.12 0.10 (0.06 to 0.14) ,0.001
4.94 6 0.50 0.14 (20.01 to 0.30) 0.017
0.92 6 0.11 0.13 (20.04 to 0.06) ,0.001
166 6 43 32 (20 to 45) ,0.001
90 6 18 17 (11 to 22) ,0.001
40 6 9 8 (6 to 10) ,0.001
10 (16) 15.6† ,0.001
0.37 6 0.05 0.04 (0.02 to 0.06) ,0.001
38 6 6 2 (20.003 to 0.04) 0.12
78 6 18 7 (1 to 13) NS
42 6 9 3 (1 to 6) NS
Table 4—Continued
Patients with Sustained
Hypertension (n 5 64)
Difference in Mean Values
between Sustained
Normotension Group and
Sustained Hypertension
Group (95% CI)
P
Value
0.85 6 0.19 0.16 (0.11 to 0.22) ,0.001
5.76 6 0.63 0.46 (0.24 to 0.69) ,0.001
17.8 6 5.0 4.7 (3.1 to 6.3) ,0.001
0.29 6 0.06 0.03 (0.01 to 0.05) ,0.001
17 (27) 13† ,0.05
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role in predicting target organ damage (26–29) or
clinical outcome (4, 6). Compared with patients
with sustained normotension, patients with white
coat normotension had significantly higher left ven-
tricular wall thickness and mass. Left ventricular
mass index was similar, on average, in patients with
white coat normotension (86 g/m2) and those with
sustained hypertension (90 g/m2), despite an aver-
age difference in clinic blood pressure of 35/16 mm
Hg between these groups. In part, the similarity of
left ventricular mass in these two groups is probably
due to the smaller average difference of 14/6 mm
Hg in awake ambulatory blood pressure and the
known closer correlation of left ventricular mass
with ambulatory blood pressure than with casual
blood pressure (5, 10, 11, 26, 27). An additional
factor that may contribute to the similarity of left
ventricular mass in patients with white coat normo-
tension and those with sustained hypertension is the
greater stroke volume in the former group; this
finding is consistent with previous documentation of
stroke volume as an important stimulus that con-
tributes to left ventricular hypertrophy (30–32).
Compared with patients with sustained normo-
tension, patients with white coat normotension had
greater carotid artery wall thickness and cross-
sectional area, as well as a higher prevalence of dis-
crete atherosclerotic plaque, although the arterial dif-
ferences became insignificant in multivariate analysis.
Unlike the situation with left ventricular mass, few
studies have compared the impact of clinic and am-
bulatory pressures on arterial structure. One study
(11) showed that carotid wall thickness in patients
with white coat hypertension was normal, reflecting
the normal ambulatory blood pressure rather than
the elevated clinic pressure in these patients.
Greater obesity, higher cholesterol levels, and a
trend toward more use of nicotine was seen among
patients with white coat normotension compared
with those with sustained normotension. The sug-
gestive evidence of a relation between nicotine use
and white coat normotension is consistent with pre-
vious data showing that smokers have a higher am-
bulatory blood pressure than nonsmokers (33, 34).
The former associations are consistent with the
known relation between overweight and arterial
blood pressure and cholesterol levels. Although in-
verse cross-sectional relations between smoking and
blood pressure, attributed to a rebound reduction in
blood pressure caused by abrupt cessation of smok-
ing during office visits, have been reported, exclu-
sion of current smokers did not affect the statistical
significance of our results.
Our findings may help to explain previous obser-
vations of clinical benefit of reducing arterial blood
pressure to below the conventional partition values
of 140/90 mm Hg. In the Treatment of Mild Hy-
pertension Study (35), the event rate was lower in
patients with mild hypertension and a high preva-
lence of overweight and dyslipidemia in whom ar-
terial pressure was decreased to a mean of 126.7/
79.4 mm Hg by medication plus lifestyle intervention
than in patients whose blood pressure was de-
creased to 132.6/81.9 mm Hg with nutritional and
hygienic intervention alone. The Hypertension Opti-
mal Treatment trial (36) showed that diastolic blood
pressure could be safely reduced to target levels less
than 90 mm Hg; evidence suggested that the opti-
mal diastolic pressure level was about 82 mm Hg.
Finally, the United Kingdom Prospective Diabetes
Study (37) showed that cardiovascular event rates in
diabetic patients were lowest if diastolic blood pres-
sure was reduced below 80 mm Hg. Although am-
bulatory blood pressure data are not available in the
large randomized clinical trials, it is possible that
participants in these trials who had high normal
clinic blood pressure while receiving treatment had
a high prevalence of ambulatory hypertension and
associated target organ damage (as was seen in our
unmedicated patients) that could have been re-
versed by further reduction of arterial pressure.
One limitation of our study is its cross-sectional,
nonrandomized design. The prospective sampling of
patients with normotension from specified employee
groups eliminates clinical referral bias but leaves
open the possibility that some patients may have
chosen to participate because they knew that they
had previous borderline or elevated blood pressure.
Additional epidemiologic studies will be needed to
define the population prevalence of white coat nor-
motension. The use of a single measurement of
ambulatory blood pressure to distinguish white coat
normotension from sustained normotension may
have resulted in some misclassification, although use
of partition values of 134/90 mm Hg from a single
set of awake blood pressure measurements has been
shown to be useful in identifying patients with white
coat hypertension who are at low risk for target
organ damage (10, 11) and subsequent clinical
events (4). Although the ability of echocardiography
to measure left ventricular mass is not perfect, use
of this test is supported by studies showing high
correlation (r 5 0.90) between left ventricular
weight assessed by echocardiography or by necropsy
(20) and high reproducibility of left ventricular mass
on serial measurements (rho 5 0.93) (38). Echocar-
diographic left ventricular hypertrophy has been
consistently shown to predict high cardiovascular
event rates (39, 40). This supports its use in our
study as a provisional surrogate outcome. Recent
data suggest that ultrasonographic detection of in-
creased carotid wall thickness and plaque also predicts
adverse outcomes (41). However, the true prognostic
significance of white coat normotension must be
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defined in prospective observational studies and
randomized clinical trials that use actual morbid
event rates. Additional research in populations large
enough to stratify patients by body mass index and
serum cholesterol level is needed to confirm the
statistical independence from these confounders of
the relation between white coat normotension and
left ventricular hypertrophy. Future studies may also
determine whether the subtle difference in serum
creatinine level that we observed between patients
with white coat normotension and those with sus-
tained normotension reflects an underlying abnor-
mality that could have both pressor and proathero-
genic effects.
Our finding of a stepwise increase in the preva-
lence of white coat normotension from 11% in pa-
tients classified by JNC-V criteria as having optimal
pressure to 37% in those having high-normal pres-
sure parallels the gradient in cardiovascular risk
among patients with normotension on which the
JNC-V subclassification was based (17, 42). Thus,
our observations may provide mechanistic insight
into the occurrence of cardiovascular morbid events
in patients with normotension revealed by epidemi-
ologic research. Although our cross-sectional study
supports the hypothesis that patients with white coat
normotension, who have mildly elevated ambulatory
pressures, represent a high-risk group, this conclu-
sion must be regarded as tentative until long-term
prospective studies determine whether white coat
normotension is associated with an elevated rate of
cardiovascular events. Further research is also needed
to determine whether it is cost-effective to use ambu-
latory blood pressure recording to detect this subgroup
of persons with normotension.
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